Webinars

Earlier Webinars

• What's new for colorectal cancer treatment? (Oct 13, 2022)
• Supporting treatment with good nutrition (Oct 13, 2022)
• What's new for gynecologic cancer treatment? (Oct 12, 2022)
• Breast Reconstruction Panel: Live Q&A Panel (Oct 12, 2022)
• What's new for pancreatic cancer treatment? (Oct 12, 2022)
• What's new for people with Lynch syndrome? (Oct 12, 2022)
• Screening, prevention and gender affirming care for transgender people with mutations (Oct 12, 2022)
• What are liquid biopsies and what is their role in screening and treatment of gynecologic cancers? (Oct 12, 2022)
• Medical marijuana 101; What to know, where to go, what we are learning (Oct 12, 2022)
• What's new for hereditary breast cancer treatment? (Oct 12, 2022)
• What's new in gynecologic cancer detection and prevention? (Oct 12, 2022)
• How palliative care can help people at any stage of diagnosis (Oct 12, 2022)
• 5 Questions About Breast Reconstruction: What Everyone Wants to Know (Oct 12, 2022)
• What's new for people with ATM, CHEK2 or PALB2 mutations? (Oct 12, 2022)
• Is this my new normal? Navigating life detours due to risk management or treatment (Oct 12, 2022)
• Strategies for cancer interception and prevention in individuals with hereditary cancer syndromes (Oct 12, 2022)
• Why am I so tired? Managing fatigue due to treatment or prevention (Oct 12, 2022)
• What's new for pancreatic cancer detection? (Oct 12, 2022)
• Cancer Risks, Screening and Prevention for People with Lynch Syndrome (Sep 29, 2021)
• What You Should Know about Breast Implants (Sep 29, 2021)
• Biomarkers and Liquid Biopsies (Sep 29, 2021)
• Going Flat After Mastectomy (Sep 29, 2021)
• What’s New in Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer (Sep 29, 2021)
• What's New in Hereditary Cancer - Lynch Syndrome (Sep 29, 2021)
• Breast Reconstruction Q & A Panel (Sep 29, 2021)
• Breast Reconstruction Overview (Sep 29, 2021)
• Looking Behind the Headlines to Understand Cancer in the News (Sep 29, 2021)
• Black Men: Overcoming Prostate Cancer Disparities through Screening, Prevention and Genetics (Sep 29, 2021)
• What's New in Pancreatic Cancer Screening and Prevention? (Sep 29, 2021)
• What's New in Prostate Cancer Treatment? (Sep 29, 2021)
• What's New in Colorectal Cancer Treatment? (Sep 29, 2021)
• Targeted Therapies and Immunotherapies Q & A Panel (Sep 29, 2021)
• What's New in Pancreatic Cancer Treatment (Sep 29, 2021)
• What's New in Breast Cancer Treatment? (Sep 29, 2021)
• What's New in Gynecologic Cancer Screening and Prevention? (Sep 29, 2021)
• What's New in Gynecologic Cancer Treatment? (Sep 29, 2021)
• Hereditary Cancer Genetics, Risk and Management Q & A Panel (Sep 29, 2021)
• Cancer Risks, Screening and Prevention for People with ATM, CHEK2, PALB2 and Other Genes (Sep 29, 2021)
• What are Targeted Therapies and Immunotherapies? (Sep 29, 2021)
• Hereditary Cancer Q&A Panel (Sep 21, 2021)
• How Do I Decide? Finding Clarity in Decision-Making (Sep 21, 2021)
• Cancer Risks, Screening and Prevention for People with BRCA1 or BRCA2 Mutations (Sep 21, 2021)
• Colorectal Cancer Screening and Prevention in High-Risk Individuals (Apr 19, 2021)
• Hereditary Prostate Cancer Treatment (Nov 20, 2020)
• Maintenance Therapy Options for Ovarian Cancer (Oct 1, 2020)
• Basics of Hereditary Ovarian Cancer Diagnosis and Treatment (Dec 2, 2017)
• Exploring Your Family Planning Options Through Assisted Reproduction as a Cancer Previvor or Survivor (Apr 25, 2016)
• Breast Reconstruction Options (Oct 19, 2015)
• Pros and Cons of Hysterectomy at the Time of Risk-reducing Removal of Ovaries and Fallopian Tubes (Dec 7, 2014)